Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.
Johnson S, Oliver C, Prince GA, Hemming VG, Pfarr DS, Wang SC, Dormitzer M, O'Grady J, Koenig S, Tamura JK, Woods R, Bansal G, Couchenour D, Tsao E, Hall WC, Young JF.
Johnson S, et al. Among authors: prince ga.
J Infect Dis. 1997 Nov;176(5):1215-24. doi: 10.1086/514115.
J Infect Dis. 1997.
PMID: 9359721